Real-world Aliskiren Use in Diabetic Patients

Novartis

Status: Completed

Conditions: Hypertension; Diabetes

Study type: Observational

Funder types: Industry

Identifiers

NCT01393860

HEORUS0081

Details and patient eligibility

About

The purpose of this study is to evaluate real-world patterns of aliskiren use with a focus of change in renal function following aliskiren initiation as well as to identify "triggering events" that lead to aliskiren initiation.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 diabetes
• Patients ages 18 yeras and older
• Hypertension Diagnosis
• Currently on at least 1 hypertensive medication
• At least 2 lab measure before and after aliskiren initiation

Exclusion criteria

• Inadequate chart records where microalbuminuria, serum creatinine and blood pressure data are not within 3-12 months prior to initiation of Aliskiren
• Pregnancy
• Development of secondary renal disease unrelated to diabetes (such as nephritis)
• Terminal illness
• AIDS/HIV Other protocol-defined inclusion/exclusion criteria may apply

Trial design

200 participants in 1 patient group

Aliskiren

Description:

Diabetic nephropathy